Morepen Laboratories share news, announcements and annual reports
NSE: MOREPENLABBSE: 500288Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹113.35.
2 Nov: open ₹107.69, high ₹107.69, low ₹107.69
- Under NSE's long-term additional surveillance, stage IV, on the list for 2 Nov 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,901 Cr1,108th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 31.30
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.27
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.19%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 14.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.22
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 8,39,229
Morepen Laboratories routine notices
323 filed, newest first. Page 5 of 7.
Mar 2022
4 Mar · Routine
3 Mar · Routine
Feb 2022
21 Feb · Routine
Jan 2022
20 Jan · Routine
Dec 2021
23 Dec · Routine
20 Dec · Routine
Nov 2021
26 Nov · Routine
17 Nov · Routine
13 Nov · Routine
Oct 2021
23 Oct · Routine
18 Oct · Routine
12 Oct · Routine
8 Oct · Routine
1 Oct · Routine
Sep 2021
22 Sep · Routine
22 Sep · Routine
16 Sep · Routine
13 Sep · Routine
13 Sep · Routine
3 Sep · Routine
Aug 2021
31 Aug · Routine
27 Aug · Routine
18 Aug · Routine
17 Aug · Routine
13 Aug · Routine
12 Aug · Routine
10 Aug · Routine
Jul 2021
31 Jul · Routine
28 Jul · Routine
22 Jul · Routine
19 Jul · Routine
13 Jul · Routine
9 Jul · Routine
7 Jul · Routine
2 Jul · Routine
Jun 2021
30 Jun · Routine
29 Jun · Routine
23 Jun · Routine
22 Jun · Routine
17 Jun · Routine
14 Jun · Routine
Apr 2021
23 Apr · Routine
17 Apr · Routine
12 Apr · Routine
1 Apr · Routine
Mar 2021